Beryl Drugs Limited (BOM:524606)

Market Cap	116.65M +13.4%
Revenue (ttm)	215.51M +9.4%
Net Income	6.25M +169.1%
EPS	1.25 +176.8%
Shares Out	5.07M
PE Ratio	18.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,114
Open	22.55
Previous Close	23.00
Day's Range	22.00 - 23.39
52-Week Range	15.92 - 30.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In fiscal year 2026, Beryl Drugs's revenue was 188.20 million, a decrease of -11.00% compared to the previous year's 211.46 million. Earnings were 4.25 million, a decrease of -26.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 18, 2026

Data Sources Report a data error